Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ANB-2 by Biocad for Hemophilia B (Factor IX Deficiency): Likelihood of Approval
ANB-2 is under clinical development by Biocad and currently in Phase II for Hemophilia B (Factor IX Deficiency). According to...